FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1079-1080 October 8, 1998 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Goble, M. Related Article by Pablos-Méndez, A. PubMed Citation

To the Editor: The article "Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997" by Pablos-Méndez et al. (June 4 issue)¹ is a clarion call to action by governments and health officials worldwide to combat the increasing prevalence of multidrug-resistant tuberculosis. The prevalence of this disease may in fact be higher than reported, because of two limitations of the study. First, data from regions in which the disease is highly endemic, such as China and most of India, were not obtained. Second, the study included relatively few countries in Africa and none in the Middle East. Furthermore, the ongoing pandemic of human immunodeficiency . . . [Full Text of this Article]

References

This article has been cited by other articles:

• GEERLIGS, W A, VAN ALTENA, R, VAN DER WERF, T S (2001). Systemic effects of inhaled steroids.. Thorax 56: 980-981 [Full Text]  
• Espinal, M. A., Laszlo, A., Simonsen, L., Boulahbal, F., Kim, S. J., Reniero, A., Hoffner, S., Rieder, H. L., Binkin, N., Dye, C., Williams, R., Raviglione, M. C., the World Health Organization-International Union, (2001). Global Trends in Resistance to Antituberculosis Drugs. NEJM 344: 1294-1303 [Abstract] [Full Text]